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ABSTRAK 
 
 
 
 
Kajian ini bertujuan mengenal pasti tanda-tanda klinikal yang dipamerkan oleh 
tikus apabila terdedah kepada produk Krim Gamat - N,N-diethyl-m-toluamide (DEET) 
Penghalau Serangga (GDMRC). Produk ini mengandungi N,N-diethyl-m-diethyl (15 
percent berat per berat) sebagai bahan aktif dengan bioaktiviti menghalau nyamuk dan 
Krim Gamat (GC) sebagai bahan plasebo. Kajian ini dilakukan untuk menentukan 
kategori bahaya ketoksikan kulit akut bagi GDMRC seterusnya mengklasifikasikan ia 
berdasarkan Kelas Racun Bahaya WHO dan klasifikasi harmoni bahan kimia berbahaya 
UN-GHS. Data kajian menyediakan sebahagian daripada data keselamatan yang 
diperlukan untuk tujuan pendaftaran produk di mana melalui laluan pendedahan kulit 
adalah pasti kerana item ujian adalah bertujuan untuk permohonan topikal pada kulit 
manusia. Kajian ini menggunakan kaedah seperti yang dinyatakan dalam Garis Panduan 
Ujian OECD 402. Keputusan menunjukkan bahawa semua haiwan yang didedahkan 
sama ada dengan GDMRC atau GC sehingga hari ke 14 terselamat tanpa kematian, 
hampir menemui ajal, sakit teruk atau kesusahan yang teruk. Tiada tanda-tanda klinikal 
yang berterusan atau tidak berbalik, diperhatikan sepanjang 14 hari pemerhatian. 
Kesimpulannya, GDMRC memenuhi Kelas U dalam Kelas Ketoksikan Bahaya WHO 
dan Kategori 5 dalam Kategori Ketoksikan Akut Bahaya UN-GHS. Maka, untuk 
penggunaan biasa, GDMRC tidak mempunyai kebangkalian untuk mendatangkan 
bahaya akut kepada kulit. 
 xi 
ABSTRACT 
 
 
 
 
The study is aimed to identify clinical signs exhibited by rats upon single 
exposure of Gamat – N,N-diethyl-m-toluamide (DEET) Mosquito Repellent Cream 
(GDMRC) containing 15 percent of N,N-diethyl-m-toluamide as the active ingredient 
with bioactivity (repellent) against mosquitoes which includes Gamat Cream (GC) as 
the placebo item. The study is performed to determine the hazard category of acute 
dermal toxicity of the GDMRC subsequently to classify it based on the WHO Pesticide 
Hazard Class and the UN-GHS harmonized classification of hazardous chemical 
substances. The study data provides a part of the safety data required for registration 
purpose of the test item, where exposure by the dermal route is definite because the test 
item is intended for human topical application on skin. The study employs method as 
described in the OECD Test Guideline 402. Results showed that all test animals dosed 
either with the GDMRC or the GC, survived until day-14 without mortality, moribund, 
severe pain or severe distress. There was no persistent or non-reversible clinical signs 
observed between day-1 until day-14.The study concludes that the GDMRC satisfies the 
hazard toxicity class of Class U based on WHO Recommended Classification of 
Pesticides by Hazard (WHO, 2010) and the Category 5 of Acute Toxicity Hazard 
Categories under the United Nations Globally Harmonized System for Classification of 
Chemical Substances and Mixtures (UN-GHS). Therefore, the GDMRC is unlikely to 
present acute hazard upon dermal contact under normal use. 
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CHAPTER 1  
INTRODUCTION 
Dengue is a tropical and subtropical mosquito-borne viral disease and has been a 
major health concern especially in Malaysia (Chew et al. 2012). It was estimated about 
50 million dengue cases worldwide every year (WHO 2009). Dengue infection is 
related to seasons due to higher activity after monsoon. Dengue virus is spreads by 
Aedes aegypti and Aedes albopictus mosquito and develops dengue fever (DF), dengue 
hemorrhagic fever (DHF) and dengue shock syndrome (DSS). 
DF and DHF have become a major health problem in Malaysia as the cases 
increased dramatically from year 1988 to 1998. Ministry of Health Malaysia reported 
that there were 26,240 cases of DF and 1,141 cases of DHF at the time of 1998 outbreak 
(Chew et al. 2012). Extensive development and urbanization created more breeding 
areas of mosquitoes and this resulted in higher incidence of dengue viral infections.  
In view no vaccine, specific antidote and medications are available, preventive 
measure against dengue infection is crucial. Wearing protective clothing and application 
of insect repellent to the skin are the common approach in avoiding mosquitoes bites 
(Peter & Mwangi 2014). Two major types of commercial insect repellents available are 
synthetic chemicals and plant derived essential (Fradin & Day 2002). For the past 60 
years, synthetic mosquito repellent, N,N-diethyl-meta-toluamide (DEET) was used 
worldwide (Isman & Grieneisen 2014). DEET is the most effective active ingredient for 
insect repellent (Moore & Debboun 2007) due to its longer protection time and 
inexpensive. Among commercial DEET formulations are aerosol/spray, creams, liquids, 
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roll-ons, towellettes, lotions, and impregnated wrist bands (Wilson et al. 2013). 
In the study, Gamat-DEET Mosquito Repellent Cream (GDMRC) is an insect 
repellent product of cream formulation designed for topical application by end user at 
home. It is regarded as insecticide product and going to be marketed in Malaysia. In 
view the GDMRC via topical application causes direct exposure to human, the Malaysia 
Pesticide Board has mandated for any pesticide product to be registered for sale or 
distribution in Malaysia shall furnish non-clinical safety data (Pesticide Act 1974). 
Among the requirements for registration are safety data in form of acute dermal toxicity, 
acute oral toxicity, skin irritation and skin sensitization. Therefore, the study addresses 
acute dermal toxicity test. Acute dermal toxicity result will also be utilized in 
determining the hazard class of the insecticide product based on World Health 
Organization (WHO) Recommended Classification of Pesticides by Hazard as described 
in Table 1.1 (WHO 2010) that has been aligned with the Acute Toxicity Hazard 
Categories under the United Nations Globally Harmonized System for Classification of 
Chemical Substances and Mixtures (UN-GHS), whereby the GDMRC shall be only 
permitted for intended regular skin application if it meets the WHO Hazard Class U and 
the UN-GHS Category 4 and above. 
The study specifically includes the cream base as the placebo item. The 
inclusion of the Gamat Cream (GC) as the placebo item is to verify any possible toxicity 
of the base formulation in view of none availability of prior safety data. Thus, the study 
is performed with the purpose to determine the acute dermal toxicity of GDMRC based 
on the harmonized UN-GHS toxic class with three main objectives which are: 
1. To identify clinical signs exhibited by the rats upon single dosing of the test 
item (GDMRC) and the placebo item (GC), subsequently determining the 
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need for repeated dose toxicity study based on the outcome of the necropsy 
gross examination. 
2. To determine the hazard category of the test item (GDMRC) based on the 
UN-GHS classification, subsequently concluding the suitability for sale 
under the group of household insecticide product which only accepts 
products with Hazard Category 4 and above. 
3. To determine the hazard category of the placebo item (GC), to elucidate the 
possible toxicity contributed by the inert ingredients. 
The outcome of the study shall provide a part of the safety data required for 
registration purpose of the test item (GDMRC) and shall provide information on health 
hazards likely to arise from a short term exposure (24 hours) to the test item by means 
of the dermal route. Therefore, the test item can be marketable under the group of 
household insecticide product in Malaysia and also in European Country in the future. 
In the other hand, this study also promotes the use of mosquito repellent among the 
society in order to prevent dengue cases. 
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Table 1.1 WHO Recommended Classification of Pesticides by Hazard 
WHO Pesticide Hazard Class LD50 for the rat (mg/kg body weight) 
  Oral Dermal 
Ia  
Ib  
II  
III  
U  
Extremely hazardous 
Highly hazardous 
Moderately hazardous 
Slightly hazardous 
Unlikely to present acute hazard 
< 5 
5 – 50 
50 – 200 
> 2000 
≥ 5000 
< 50 
50 – 200 
200 – 2000 
> 2000 
≥ 5000 
(WHO 2010) 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 United Nations Globally Harmonized System for Classification and 
Labeling of Chemical Substances and Mixtures (UN-GHS) 
2.1.1 Purpose of UN-GHS 
United Nations Globally Harmonized System for Classification and Labeling of 
Chemical Substances and Mixtures (UN-GHS) was developed at the Rio Summit in 
1992. United Nation Economic and Social Council has adopted UN-GHS and endorsed 
by World Summit for Sustainable Development (WSSD) to be implemented in 2008. In 
view that the presence of multiple existing laws or regulations on chemical 
classification and labeling such as United Nations Dangerous Goods System, European 
Country (EC) system for hazardous substances (Winder et al. 2005) and in Malaysia, 
Chemical Packaging and Labeling (CPL) Regulation 1997 (OSHA 1994) have 
variations in definitions of hazards and caused confusion at user level, UN-GHS is 
purposely developed to standardize worldwide safe chemical management issues from 
manufacturer, transport, usage and disposal (Winder et al. 2005). 
UN-GHS is an internationally agreed system for hazard classification and 
communication of chemical products (Pratt 2002) and was developed through a 
collaborative effort of various organizations such as WHO, International Labor 
Organization, Organization for Economic Cooperation and Development (OECD), 
United Nations, member countries of the organizations and support for chemical 
industries (Winder et al. 2005). 
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UN-GHS implementation is intended to provide an internationally 
comprehensible system for hazard communication, to provide a recognized framework 
for those countries without an existing system, to reduce the need for testing and 
evaluation of chemicals, and to facilitate international trade in chemicals whose hazards 
have been properly assessed and identified on an international basis (Pratt 2002).  
The scope of the UN-GHS is based on the mandate from the 1992 United 
Nations Conference on Environment and Development (UNCED), which stated that 
hazard classification and labeling system of chemicals should be harmonized and 
compatible worldwide and feasible by the year 2000. Since then, UN-GHS was 
developed and improvised. The UN-GHS includes these two main elements which are 
harmonized criteria for classifying substances and mixtures according to their health, 
environmental, and physical hazards and harmonized hazard communication elements, 
including requirements for labeling and safety data sheets (UN-GHS 2011). 
2.1.2 Hazard Classification 
As an internationally agreed system for classification and labeling of chemical 
substances and mixtures, UN-GHS classified them in terms of physical hazard, health 
hazard and environmental hazard as described in Table 2.1 (UN 2011) which covers 
range of consumer products, workplace, pesticides and transportation. Implementation 
of UN-GHS does not only protect human health and environment but indirectly promote 
chemical trade between countries all over the world (Thannimalay & Yusoff 2008). 
UN-GHS hazard classification includes the compilation of all relevant data need 
to be carried out by the supplier in order to place the item on the European Union 
market. In order to determine the hazard class, a cut off values for maximum levels is to 
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Table 2.1 UN-GHS Classification of Chemical Substance and Mixtures  
Hazard Classification Types of Chemical Substances and Mixtures 
Physical hazard Explosives 
Flammable gases 
Flammable liquids 
Flammable solids 
Oxidizing gases 
Oxidizing liquids 
Oxidizing solids 
Health hazard Corrosive to metals 
Skin corrosions 
Acute toxicity 
Skin irritants 
Carcinogenicity 
Environmental hazard Acute hazardous to the aquatic environment 
(UN 2011) 
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be considered when evaluating test result of animal experiments. These cut-off values 
reflect a threshold between toxicological relevance and non-relevance to humans, 
whereby it covers all exposure situations presumably appearing under real-life 
conditions. Hence, a proper labeling is required to identify and specify the hazard class 
of the product (Gebel et al. 2009). 
UN-GHS hazard communication is based on the provision of signal words, 
hazard statements and pictograms. All of these are connected to the specific hazard of 
the substances or mixtures (Silk 2003). Regulation (EC) No. 1907/2006 subjecting the 
Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) entered 
into force in 2007 and represents a major piece of chemical legislation in Europe. One 
of the main objectives of the regulation is to ensure a maximum level of humans and 
environment protection. In achieving this objective, the chemical substances and 
mixtures are classified according to their physicochemical, environmental or human 
health hazards (Oltmanns et al. 2014). Based on the classification as described in Table 
2.1, the study omitted acute toxicity that is under class of health hazard.  
2.1.3 Health Hazards 
Health hazard is defined as a substance for which there is statistically significant 
evidence based on at least one study conducted in accordance with established scientific 
principles that acute or chronic health effects may occur in exposed human. Health 
hazard chemicals include chemicals which are carcinogens, toxic or highly toxicagents, 
reproductive, toxins, irritants, corrosives, sensitizers, hepatotoxins, nephrotoxins, 
neurotoxins, agents which act on the hematopoietic system, and agents which damage 
the lungs, skin, eyes, or mucous membranes (UNECE 2003). 
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 Health hazard classification covers criteria in terms of acute toxicity, skin and 
eye irritation/corrosion, danger of irreversible effects after single exposure and danger 
of serious damage to health by prolonged exposure (Gebel et al. 2009). Below are the 
summarizations of all the criteria that have been developed for the health hazard 
groupings (Winder et al. 2005; UN 2011): 
 Single dose toxicity, covering a range of toxicity endpoints by various routes 
of exposure (Table 2.2). 
 Skin irritation and corrosion. Category 1 is for corrosive effects and 
Categories 2 and 3 for irritation (Table 2.3). 
 Eye irritation and serious eye damage. Category 1 is for corrosive effects and 
Categories 2A and 2B for irritation (Table 2.3). 
 Skin or respiratory sensitization. If evidence is available to allow 
classification of sensitization, both skin and respiratory sensitization are in 
Category 1, but note the new symbol for serious effects for respiratory 
sensitization (Table 2.4). 
 Single or repeated dose target organ systemic toxicity (TOST). This uses 
similar criteria for both single and repeated exposures (Table 2.4). 
 Genotoxicity and germ cell toxicity. As with the EC criteria, there are two 
categories (Table 2.5). 
 Reproductive toxicity. Reproductive toxicity includes adverse effects on 
sexual function and fertility in adult males and females, as well as 
developmental toxicity in the offspring (Table 2.5). 
 Carcinogenicity. As with the EC criteria, there are two broad categories 
(Table 2.6). 
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2.1.4 Acute  Toxicity 
Acute toxicity refers to those adverse effects presented upon single dose of a 
substance, or multiple doses given within 24 hours via oral or dermal administration, or 
by inhalation exposure of 4 hours. Chemicals can be categorized to one of five toxicity 
categories based on acute toxicity by the oral, dermal or inhalation route according to 
the numeric criteria expressed as LD50 (oral and dermal) or LC50 (inhalation) (UN 
2011). 
Acute systemic toxicity testing is defined as the potential of a substance to 
produce human hazard by determining its systemic toxicity in a test system based on the 
median lethal dose (LD50) value which means 50 percent of the test animal will be 
killed upon exposure of a single dose of the test substance. In order to have systemic 
toxic effects, a toxic substance must be absorbed by the body and distributed by the 
circulation, subsequently exerts its toxic effects. The observed toxicity is a result of 
liver biotransformation to convert a substance to a new form or metabolites. Depending 
on the route of exposure, acute systemic toxicity is assessed following oral, dermal and 
inhalation exposure. 
The development of harmonized test method as the basis of any risk assessment 
procedure was established by the OECD‟s Environment, Health and Safety (EHS). 
Being considered as the leading international standard for safety testing and the 
development of new Test Guidelines (TG), the OECD Test Guidelines plays a vital role 
on testing and assessment. Together with GLP Principles, OECD Test Guidelines form 
an integrated part of the Council Decision on the Mutual Acceptance of Data (MAD) 
(Barlow et al. 2002). 
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 Table 2.2 UN-GHS criteria, Single dose toxicity  
  Toxic Category 
 1 2 3 4 5 
 
 
Oral 
(mg/kg) 5 50 300 2000 Oral LD50 
between 
2000 and 
5000 mg/kg. 
Indication of 
significant 
effect in 
humans. 
Any 
mortality in 
Category 4. 
Dermal 
(mg/kg) 50 200 1000 2000 
Gases 
(ppm) 100 500 2500 5000 
Vapor 
(mg/L) 0.5 2 10 20 
Dust and 
mists 
(mg/L) 
0.05 0.5 1 5 
(UN 2011) 
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Table 2.3 UN-GHS criteria, skin corrosion/irritation and serious eye damage/eye 
irritation  
Skin corrosion/irritation  
Destruction of skin tissue; 
visible necrosis in one or more 
of three animals 
 
Reversible adverse effects in skin tissue 
 
Category 1 Category 2 Category 3 
   
  
No pictogram 
Subcategory 1A 
Exposure: 3 min or less 
Observation: Up to 60 min 
Exposure: 3 min Mean irritation score 
of 1.5–2.3 for 
erythema/eschar or for 
edema in at least two 
or three tested animals 
at 24, 48 and 72 hours.   
Subcategory 1B 
Exposure: 3 min and 1 hour 
Observation: Up to 14 days 
Subcategory 1C 
Exposure: 1 to 4 hours 
Observation : Up to 14 days 
Serious eye damage/eye irritation  
Category 1 Category 2 
 
 Subcategory 2A Subcategory 2B 
 Reversible in 21 days Reversible in 7 days 
 
 
 
Adverse effects on 
conjunctiva, cornea, iris that 
have not reversed within the 
observation period (normally 
21 days after exposure) in at 
least one animal,  
 
and/or 
 
In at least two of three tested 
animals, a positive response 
of corneal opacity with a 
mean score of 3 or above, 
and/or a mean score of more 
than 1.5 for iritis, at 24, 48 
and 72 hours. 
Reversible adverse effects on conjunctiva, 
cornea, iris. 
 
Mean irritation score in at least two of three tested 
animals of 1 or more for corneal opacity and or 1 
or more for iritis, and/or mean scores of 2 or more 
for redness and/or 2 or more for conjunctival 
edema (chemosis). 
(UN 2011) 
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Table 2.4 UN-GHS criteria, respiratory or skin sensitization and single or repeated target 
organ systemic toxicity (TOST)  
Respiratory or skin sensitization 
 
Respiratory  
Category 1 
 
Skin  
Category 1 
  
  
  
Evidence in humans of specific 
respiratory sensitivity and/or Results 
of respiratory sensitivity from animal 
studies. 
Evidence in humans of sensitization 
by skin contact in a substantial 
number of persons, or Results of 
skin sensitivity from appropriate 
animal studies. 
Single or repeated target organ systemic toxicity (TOST) 
 
Category 1 
 
Category 2 
Significant toxicity in humans Presumed to be harmful to human health 
 
 
 
 
  
Reliable, good quality human case 
studies or epidemiological studies. 
 
Presumed significant toxicity in humans. 
 
Animal studies with significant and/or 
severe toxic effects relevant to humans at 
a generally (as a guide) low exposures. 
Animal studies with significant toxic 
effects relevant to humans at generally 
moderate (as a guide) exposure. 
 
Human evidence in exceptional cases. 
(UN 2011)
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Table 2.5 UN-GHS criteria, germ cell mutagenicity and reproductive and developmental 
effects  
Germ cell mutagenicity 
 
Category 1 
 
Category 2 
 
 
 
 
 
Subcategory 1A  
 
Known to produce heritable mutations 
in human germ cells. 
 
Positive evidence from human 
epidemiological studies. 
 
May induce heritable mutations in 
human germ cells. 
 
Positive evidence from tests in mammals 
and somatic cell tests. 
 
In vivo somatic genotoxicity supported 
by in vitro mutagenicity. 
 
Subcategory 1A 
 
Should be regarded as if they produce 
heritable mutations in the germ cells of 
humans, 
 
Positive results in: 
 
Human germ cell tests, 
In vivo heritable germ cell tests in 
mammals, 
In vivo somatic mutagenicity tests, 
combined with some evidence of germ 
cell mutagenicity. 
Reproductive and developmental effects 
 
Category 1 
 
Category 2 
 
 
 
 
Known or presumed to cause effects on 
human reproductive ability/capacity or on 
development. 
Suspected to cause effects on human 
reproductive ability/capacity or on 
development. 
 
Subcategory 1A  
Known (based on human data) 
 
 
Additional category effects on lactation or 
effects via lactation. 
Subcategory 1B  
Presumed (based on animal data) 
 
(UN 2011)
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Table 2.6 UN-GHS criteria, carcinogenicity 
Carcinogenicity  
 
Known or presumed human carcinogen 
 
Suspected human carcinogen 
Category 1 Category 2  
   
 
 
 
 
  
Subcategory 1A Subcategory 1B 
 
Known human carcinogen based on 
human evidence. 
 
Presumed human carcinogen based on 
demonstrated animal carcinogenicity. 
 
Limited evidence of human or animal 
carcinogenicity. 
(UN 2011)
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An extensive set of safety tests is required for registration of new industrial 
chemicals, pesticides, pharmaceutical industrial chemicals, pesticides, pharmaceuticals 
and feed additives. However, according to MAD decisions, if the data developed in one 
country is accordance to the OECD Test Guidelines and GLP Principles, they are 
accepted for assessment purposes in all OECD countries. Hence, they may save a lot by 
avoiding repetitive testing and minimizing non-tariff barriers in trading products (Koe 
2003). 
As for the universal application, the United Nations has formulated a 
classification and labeling system which is called as „Globally Harmonized System of 
Classification and Labeling of Chemicals‟ (UN-GHS) introduced in 2003 (UNECE 
2003) with the most current revision published in 2011 (UNECE 2011). The UN-GHS 
classified four or five categories depending on geographical jurisdiction based on acute 
toxicity lethality values (LD50) of experimented animals in determining the acute 
systemic toxicity of a substance. Hence, LD50 values define the category boundaries in 
which becomes the European and UN-GHS frameworks of oral and dermal routes of 
exposure (Moore et al. 2013).  
Harmonized criteria for health and environmental classification were developed 
for all of the various types of effects that were covered in the major existing systems. 
The intent is to continue this work in the OECD in the future, preferably by having 
national experts develop criteria for health or environmental effects of concern together 
so they are harmonized from the outset (Silk 2003). 
Determination of acute dermal toxicity is important in evaluating and assessing 
the toxic characteristic of a substance when the route of exposure is by dermal route. As 
a short term exposure, acute dermal toxicity gives information on health hazards likely 
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to arise. In fact, the data collected from acute dermal toxicity provides a basis for 
classification and labeling. In addition, the data is also needed in determining the dose 
for sub chronic and other studies on dermal absorption (OECD 1987). 
On the other hand, dermal toxicity testing is done to assess the local and/or 
systemic effects of a chemical after exposure to the dermal route. It only indicates either 
the penetration of a substance may produce a systemic toxicity not the amount of 
chemical absorbed (Basketter et al. 2012) 
There are five Organization for Economic Cooperation and Development 
(OECD) Test Guidelines (TG) which describes acute systemic testing namely TG 402, 
TG 403, TG 420, TG423, and TG 425. The classification of chemicals is addressed by 
UN-GHS by hazard types and proposed harmonized hazard communication elements. 
This includes hazard classification criteria, labels, and safety data sheets. Besides, UN-
GHS provides a cornerstone for harmonization of rules and regulations on chemicals at 
national, regional and worldwide levels (Sanderson & Thomsen 2009).  
In order to determine the category of classification of GDMRC, acute dermal 
toxicity data is required. Thus, OECD TG 402 is chosen to review the hazard 
classification of this substance as it uses topical application on the skin. 
2.2 Acute Dermal Toxicity Study 
Acute dermal toxicity study is designed to evaluate and assess the systemic and 
localize toxicity effects of a substance when the route of exposure is via dermal route. 
As for OECD TG 402, acute dermal toxicity is defined as application of a test substance 
to no less than 10 percent of rats, rabbits, or guinea pigs skin followed by 14 days of 
observation. LD50 is determined by the number of animal‟s death and gross 
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pathological changes are to ascertain the relative toxicity of a substance (OECD, 1987). 
In view dermal is a part of the human skin, the physiology and mechanism of 
skin absorption are explained in the next paragraphs. 
2.2.1 Anatomy and Physiology of Skin 
The skin is the largest organ of the body, with a total area of about 20 square 
feet and weighing about 5 kg with a surface area of 2 meter
2 
(Godin & Touitou 2007). 
The skin protects us from microbes and the elements, helps regulate body temperature, 
and permits the sensations of touch, heat, and cold. This multi-layered organ acts 
mainly to protect the body from the surrounding environment, thus forming an efficient 
permeation barrier. There are two main layers of skin, i.e. epidermis and dermis. 
The epidermis is the outermost layer of skin that provides a waterproof barrier 
and creates our skins color by special cells called melanocytes. The melanocytes 
produce the melanin pigment that gives a multi range of human skin colors. In 
epidermis layer, the major cell type is keratinocytes. The function of keratinocytes is to 
synthesize keratin, a protein linked by disulphide bonds to form supercoils polypeptide 
from coiled polypeptide chains (Venus et al. 2011). In this layer, it comprises of four 
compartments namely stratum basal, stratum spinosum, stratum granulosum and 
SC(SC) (Breitkreutz et al. 2013).  
Stratum basal is the basal cell layer. It is only one cell thick and the main cell is 
keratinocyte. The melanocytes are also present and comprises of 5-10 percent of the cell 
population. Stratum spinosum is the prickle cell layer. As the basal cells move towards 
the surface it form a layer of polyhedral cells connected by desmosomes and seen as 
prickles under the microscope. Langerhans cells are present in stratum spinosum layer. 
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Stratum granulosum is the granular cell layer. Keratinocytes are found in the granular 
layer which contains intracellular granules of keratohyalin. The lipid contents are 
discharged from to cells into the intercellular space plays a vital role for the barrier 
function and intercellular cohesion within the SC. The barrier properties of the skin lie 
mainly within its outermost layer of the epidermis, SC. This highly hydrophobic layer is 
composed of differentiated non-nucleated cells, corneocytes (Venus et al. 2011), which 
are filled with keratins and embedded in the lipid domain (Godin & Touitou 2007). 
The dermis is located beneath the epidermis, contains tough connective tissue, 
hair follicles, and sweat glands. In between the epidermis and dermal layer there is a 
basement membrane comprises of a thin layer of specialized extracellular matrix. As for 
the dermal layer which located under the basement layer, it consists of two regions 
which are papillary dermis and reticular dermis. In the papillary regions of the dermis it 
is composed of thin collagen fibers whereas the reticular dermis is composed of thicker, 
denser collagen fibers (Mikesh et al. 2013).  
2.2.2 Mechanism of Skin Absorption 
Skin absorption depends on a few factors that include contact area, duration of 
exposure, lipophilicity, test substance concentration, molecular weight, epidermis 
thickness and the integrity of SC (OECD 2004b). In addition, dermal penetration 
depends on the qualities of SC as it acts as an excellent barrier property by protecting 
the skin against penetration (Godin & Touitou 2007).  
The dermal penetration studies are done in order to determine the amount of a 
chemical penetrate into the skin. This ensuring the substance has the potential to be 
absorbed into systemic circulation. Dermal penetration occurs by passive diffusion and 
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proceeds with the systemic absorption. However biotransformation of the chemical 
within the skin can happen before the systemic absorption (OECD 2004a). Previous 
study showed that the biotransformation at the human skin occurs due to the fact that it 
possesses multiple cytochrome P450 isoenzymes, influx and efflux transporter proteins. 
The cytochrome P450 isoenzymes located at the skin are different from the P450 
isoenzymes in the liver but they can involve in both Phase I and Phase II metabolic 
reactions. Hence, the ultimate fate and bioavailability of a chemical may be influenced 
by dermal biotransformation (Abdallah et al. 2015). 
In dermal absorption studies, human skin is preferably chosen for in vitro study 
whereas for in vivo studies, rat skin is used to observe the effect in human exposure. Rat 
skin represent for a worst case model for human skin. Even though rat skin is 
anatomically different in terms of thinner SC and more hair follicles as to compare to 
human skin, it is more permeable to chemicals and may represent for a worst case 
model for human skin (Aggarwal et al. 2015). Although the effect of dermal absorption 
is slower, prolonged exposure may cause severe toxicity. Thus, to enhance dermal 
absorption, lipophilic agent can be used and facilitated by the solvent and emulsifier 
used in the formulation (El- Naggar et al. 2009). 
Molecules penetrate through SC via passive diffusion or via sweat glands and 
hair follicles directed towards dermis layer. The function of influx transport proteins in 
human skin in dermal uptake of xenobiotics is unknown. However, the role of Organic 
Anion Transporting Polypeptides (OATP) is highlighted in terms of mediating large 
organic cations via human keratinocytes by active transportation (Schi et al. 2003). 
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Other than the role played by SC as an epidermal barrier, other molecules such 
as xenobiotic metabolizing enzymes and transport protein act as a second biochemical 
barrier of the skin. Thus, chemical residues will be limited to the epidermis layer and 
eliminated from the exposed skin by desquamation so that it is not available for 
systemic distribution (Aggarwal et al. 2015). 
Nevertheless, four mechanisms have been found to control the problem. In view 
SC has a tightly packed lipid region; skin resistance can be reduced by disrupting the 
permeability of lipid region. This causes increasing penetration through the intercellular 
lipid matrix. Another mechanism is by increasing the drug partitioning into the SC 
through formation of ion pair between the drug and fatty acid. Other possible 
mechanism is by increasing the drug solubility into the skin by having the drug to have 
high affinity for the solvent. Lastly is by increasing drug solubility in the vehicle such 
as acidic enhancers to increase the solubility of basic drugs (Gwak & Chun 2002). 
2.2.3 Toxicity upon Dermal Exposure 
Upon dermal exposure to hazard/chemical substance, two types of toxicity 
effects can be assessed namely localized dermal toxicity effects and systemic toxicity 
effects. Based on the UN-GHS health hazard groupings, localized dermal toxicity 
effects includes skin irritation/corrosion and skin sensitizing whereas systemic dermal 
toxicity effects includes acute dermal toxicity (Winder et al. 2005). 
A localized dermal toxicity effect is an effect that is observed at the site of first 
contact, i.e. on the dermal. A systemic effect is an effect that is observed distant from 
the site of exposure, after the substance has become systemically available. In terms of 
localized dermal toxicity effects, there are a few criteria which may contribute 
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significantly to morbidity, i.e. edema, erythema/eschar formation, acanthosis, necrosis 
hyperkeratosis and papillomas, due to hazard exposure (Schaafsma et al. 2011). 
The evaluation of systemic toxicity effects is due to percutaneous absorption of 
the test material whereas the local toxicity is determined by its contact with the skin. 
The absorption of the test material can be determined from observation of these effects 
either the material is sufficient to produce systemic effects or lethality (Arteaga et al. 
2014)  
Penetration through the skin and the toxic potency are the two factors that 
responsible for systemic toxicity of a chemical exposure. Skin penetration is different 
between substances as it is depending on lipid and water solubility of chemical through 
the skin. The toxicity effect cannot be determined by the amount of chemical on the 
skin surface. Thus, internal dose can be predicted by using experimental measurement 
of permeability coefficient (Kp) and steady-state flux. The other factor is by determining 
the toxic potency of a chemical by its mechanism of action. In measuring general 
toxicity, lethal dose (LD50) of half experimental animals, the lowest observable effect 
level (LOEL) and the no observable effect level (NOEL) are taken into account. Thus, it 
is possible if a nontoxic chemical has high rate of skin penetration compared to toxic 
chemical which do not penetrate skin at all (McDougal et al. 2007). 
The world of skin cosmetics involves transdermal transportation of topically 
dermal applied substance. Other than penetrating into human skin via passive diffusion, 
topical formulation also enhance skin permeability to other bioactive ingredients. As a 
result, their percutaneous release can be evaluated and may become highly relevant for 
their quality and safety assessment (Gabbanini et al. 2009). Thus, the study focuses on 
acute dermal toxicity by employing OECD TG 402 method to elucidate systemic 
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effects. In addition, the rat was selected for this study as it may serve for the worst case 
scenario of human skin absorption study. 
2.3 Insect Repellent  
As part of personal protective measures, human contact with vector and 
nuisance arthropods will be reduced with the topical application of insect repellents. 
Repellents are used as primary importance against arthropod vectors when other 
methods are not accessible or impractical (Antwi et al. 2008). 
2.3.1 Formulation  
In view that an infected arthropod biting may result in disease transmission, the 
effectiveness of repellent products should be acknowledged to provide a prolonged 
protection from insect bites. Insect repellents can be classified into two types which are 
synthetic insect repellents and plant derived essential oil insect repellent  (Fradin & Day 
2002). DEET is considered as a gold standard of insect repellent as it is developed and 
used since World War II by the US military. It is the most effective insect repellent 
which not only can be applied on skin, but also on fabrics. Natural insect repellent 
includes citronella oil, cedar oil, lemongrass oil and some others are listed by 
Environmental Protection Agency (EPA) to have minimum risk pesticides which enable 
them to be exempted from federal regulation (Katz et al. 2008; Leal 2014). 
There are many types of residential insect repellent products including aerosol, 
mosquito coils, vaporizing mats, and liquid vaporizers which are easily accessible in the 
market (Sinha et al. 2006). These commercially available products are claimed to have 
repellency properties in repelling mosquito by the usage of botanical and natural 
remedy such citronella, eucalyptus, lemongrass and geraniol oil which have been 
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formulated into commercial repellents. However, protection time against bites may 
differ due to the volatility of botanical repellents thus it needs to reapplied time by time 
(Revay et al. 2013). 
2.3.2 Mode of Action 
Insect repellent generally is a chemical volatile substance which acts locally at a 
distance by preventing an arthropod from flying to, landing on or biting human or 
animal skin (Choochote et al. 2007). In order to maintain effectiveness of repellency 
properties, repellent must evaporate at vapor concentration at the skin surface so that 
repellent active agent may interact with an insect's olfactory system. Thus, the insect 
might repel from the host or confuse it so that it does not recognize the host (Karr et al. 
2012). 
Insect repellent may work in two ways which are either as odorant or as tastant. 
Working as an odorant, it provides a vapor barrier deterring the arthropod from coming 
into contact with the skin. The vapor produced making an offensive odor and bad taste 
and will repel the insects. The efficacy of the vapor depends on the boiling point of the 
chemical. Low boiling point chemicals will vaporize rapidly and degrade the product. 
Whereas high boiling point will create a desired repellent environment as it does not 
vaporize sufficiently. Thus, an optimum boiling point is between 230°F and 260°F to 
work effectively as insect repellent (Katz et al. 2008). As for nonvolatile compound, it 
cannot work as odorant which acts at a distance and disoriented the movement of the 
insect away from source. However, it can become a tastant by disengaging a mosquito 
from feeding (Leal 2014). Generally, the resemblance of the human skin from detection 
by insects and arthropods such as mosquito, gnats and ticks are the main function of 
insect repellent (Bissinger & Roe 2010).  
